Regulatory/Compliance Filing
Cryogenic OGS Reports No Fund Utilization Deviation
Cryogenic OGS submitted its Regulation 32 statement for the half year ended 30 September 2026, reporting no deviation or variation in IPO fund utilization.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
3
Neutral
6
Bullish
5
Bearish
27
Neutral
6
Bullish
13
Bearish
24
Neutral
0
Bullish
8
Bearish
24
Neutral
0
Bullish
8
Bearish
24
Neutral
0
Bullish
8
Bearish
24
Neutral
0
Bullish
8
View Standalone
View Standalone
Investor Presentation
Q2 FY26
Industrial Manufacturing
Industrial Products
534 Cr
Low Risk
47.5
45.9
1.7
9.8
453.00
151.00
Sales CAGR
Profit CAGR
ROE
ROCE
Regulatory/Compliance Filing
Cryogenic OGS submitted its Regulation 32 statement for the half year ended 30 September 2026, reporting no deviation or variation in IPO fund utilization.
Financial Results
Cryogenic OGS reported unaudited standalone and consolidated financial results for the half-year ended September 30, 2026, along with audited balance sheets, cash flows and limited review reports.
Board Meeting
Cryogenic OGS will consider and approve unaudited financial results for the half-year ended 30 September 2026 at its board meeting on 29 October 2026.
Cryogenic OGS Ltd (CRYOGENIC) is currently trading at 355.15 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Cryogenic OGS Limited designs and manufactures precision metering, filtration, dosing and skid-based process equipment for oil, gas, chemicals and allied fluid industries, with integrated manufacturing in Vadodara and subsidiaries including Cryogenic OGS Middle East F.Z.E and Infravolt Engineering Private Limited, serving PSUs, major OEMs and international end-users through turnkey project execution. FY26 performance was strong: revenue rose 24.1% YoY to ₹4,082.24 lakhs and PAT increased 67.2% to ₹1,018.27 lakhs, with EBITDA margins around 31.7% and PAT margins near 24.9%, supported by a zero-debt balance sheet, disciplined costs and improving operating leverage that materially boosted profitability compared to FY25. Execution momentum includes completion of a full-scope international project for Honeywell Nigeria, commencement of a 143 truck-loading skids order for Egypt, supply of metering skids to Emerson in Libya and an LNG metering skid for Honeywell USA; these contracts evidence Cryogenic OGS’s capability to deliver complex, large-scale export orders. Strategic growth initiatives include commercialising the aDENS density probe developed with a European partner, expanding into LNG and green hydrogen skids, pursuing ASME and ADNOC approvals, scaling manufacturing via a large land acquisition for a fourfold expansion, and targeted market penetration across GCC, Africa and the Americas through its UAE subsidiary.
Over the past 52 weeks, Cryogenic OGS Ltd has traded between a low of ₹151.00 and a high of ₹453.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Cryogenic OGS Ltd has a market capitalization of approximately 533.79. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Cryogenic OGS Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 47.53 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 533.79 Cr, Cryogenic OGS Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Cryogenic OGS Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Cryogenic OGS Ltd is 47.53. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.